Skytech Orion Global Corp 8-K, filed Sep 9, 2020
Skytech Orion Global Corp. (SKTG)
About this 8-K
Skytech Orion Global Corp filed this 8-K on September 9, 2020.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 8.01: Other events
UNITEDSTATES
SECURITIESAND EXCHANGE COMMISSION
WASHINGTON,DC 20549
FORM8-K
CURRENTREPORT PURSUANT
TOSECTION 13 OR 15(d) OF THE
SECURITIESEXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): September 9, 2020 (September 3, 2020)
CITRINEGLOBAL, CORP.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 000-55680 | 68-0080601 |
|---|---|---|
| (State<br> or Other Jurisdiction<br><br> <br>of<br> Incorporation) | (Commission<br><br> <br>File<br> Number) | (IRS<br> Employer<br><br> <br>Identification<br> No.) |
| 3 Hamelacha St., Tel Aviv, Israel | 6721503 | |
| --- | --- | |
| (Address<br> of Principal Executive Offices) | (Area<br> Code) |
+(972) 73 7600341
(Registrant’s telephone number, including area code)
Notapplicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| [ ] | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title<br> of each class | Trading<br> Symbol(s) | Name<br> of each exchange on which registered |
|---|---|---|
| Common<br> Stock, par value $0.0001 per share | TECR | OTCQB |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangementsof Certain Officers.
On September 3, 2020, the board of directors of the Registrant increased the size of the board of directors to four directors and appointed Doron Birger (69) as a director. Mr. Birger currently serves as a director of Icecure Medical Ltd. (TASE:ICCM) and of Hera Med Ltd (ASX:HMD), and as chairman and director of several private companies in Israel in the hi-tech sector mainly in the medical device field, and as an advisor to Intelicanna Ltd (TASE:INTL). Mr. Birger served as a director of Medigus Ltd (NASDAQ:MDGS) from 2015 to 2018. From 2002 to 2007, Mr. Birger served as the chairman of the board of directors of Given Imaging Ltd. and later on as board member until February 2014. Mr. Birger served as chief executive officer of Elron Electronic Industries, Ltd., or Elron, from August 2002 to April 2009. Prior to that, he held other executive positions at Elron, including President since 2001, Chief Financial Officer from 1994 to August 2002, and Corporate Secretary from 1994 to 2001. Mr. Birger is a director of variety of non-profit organizations in Israel. Mr. Birger holds a B.A. and an M.A. in economics from the Hebrew University Jerusalem. Doron Birger will initially receive a monthly fee of NIS 5,000 (about USD 1,500) for up to two days’ work per month.
Item8.01 Other Events.
The Registrant’s Chairman and CEO has changed her name from Ora Meir Soffer to Ora Elharar Soffer.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Citrine<br> Global, Corp. | |
|---|---|
| By: | /s/ Ora Elharar Soffer |
| Name: | Ora<br> Elharar Soffer |
| Title: | Chairperson<br> of the Board and CEO |
Date: September 9, 2020